Nutriband Inc. (OTCQB: NTRB) to Host Investor Webinar to Discuss Acquisition of 4P Therapeutics Inc. & Other Important Recent Developments

Thursday, August 23, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

ORLANDO, Fla., Aug. 23, 2018 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a pharmaceutical company developing and commercializing

a portfolio of prescription pharmaceuticals, OTC's and consumer products based around the science of transdermal/topical technologies, announced today that Gareth Sheridan, CEO, will host an audio and video webinar, slide
presentation and live Q & A session for investors today (Thursday, Aug. 23, 2018) at 4:05 p.m. Eastern.

Mr. Sheridan will discuss various key events for Nutriband, among them the acquisition in April 2018 of 4P Therapeutics Inc., a company focusing on transdermal products for currently injected compounds, including proteins, peptides, macromolecules and biologics, and the transformation of 4P Therapeutics into the Pharmaceutical and Development arm of Nutriband. Mr. Sheridan will also talk about Nutriband's recent appointments to its Advisory Board, among them Sean Gallagher, a former candidate for the presidency of Ireland, who now serves as president of Nutriband.

To view the webinar, please visit

About Nutriband Inc.Nutriband is a health and pharmaceutical company based in Orlando, Florida. With the acquisition of 4P, Nutriband now has a pipeline of potential transdermal products in various stages of development. All Nutriband products are based around the science of transdermal/topical technologies. Nutriband's website is

About Our Forward-Looking StatementsCertain statements contained in this press release, including, without limitation, statements containing the words "believes," "anticipates," "expects" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. Our actual results may differ materially from those anticipated in our forward-looking statements as a result of a number of factors, including our ability to develop and market new products; our ability to complete the necessary testing in order to obtain regulatory approval; the safety and efficacy of any products we develop, our ability to obtain necessary financial to complete the regulatory process and market any products that we develop, our ability to create, sustain, manage or forecast our growth; our ability to attract and retain key personnel; changes in our business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions. Except as required by applicable law, we undertake no obligation to revise or update any of our forward-looking statements in order to reflect any event or circumstance that may arise after the date hereof. Information on our website or any other website does not constitute a part of this press release.

For more information, contact:

Gareth Sheridan CEONutriband Inc.(407)

Victor RobertsRedChip Companies (407)

Cision View original content:

SOURCE Nutriband Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store